Creganna Acquires Tactx Medical Inc.

Helen Ryan, Creganna’s CEO, says, “This move represents a key step in Creganna’s vision to build a leading global medical technology company. Tactx Medical, with its strong market reputation, is a true fit for Creganna.” She says that Creganna customers are increasingly looking to strategic partners to fulfill supply-chain requirements.

“This move firmly positions Creganna—Tactx Medical within the top 10 global providers of technologies and services to minimally invasive medical device companies,” Ryan says.

Creganna—Tactx Medical has locations in California, Minnesota, Massachusetts, Singapore, and Ireland. Combined, the two companies will offer a range of technologies and services for minimally invasive delivery and access devices, with a focus on the design and manufacturing of therapeutic catheters. Clinical applications include interventional cardiology, neurology, peripheral vascular, cardiac rhythm management and endoscopy. Creganna—Tactx Medical will have more than 800 staff worldwide and a combined revenue of $110 million for 2009. —Heather Thompson